semaglutide anesthesia guidelines considerations Relationship between perioperative semaglutide use and residual gastric content: A retrospective semaglutide asa guidelines What happened

The broader side effect landscape for GLP-1 compounds is explored in resources about semaglutide constipation management , tirzepatide digestive side effects , and tirzepatide and anxiety

- [Glucagon receptor agonism enhances energy expenditure in obese subjects]( *Cell Metabolism*, 2023

The Wegovy pill, which is a new GLP-1 tablet containing the same active ingredient as Wegovy (semaglutide), may become available in the UK in summer 2026

Recently, a phase II multicentre, double-blind, randomized controlled trial including 338 adults with obesity were administered retatrutide (1, 2 mg starting dose increased to 4, 2 mg starting dose increased to 8, 2 mg starting dose increased to 12 mg) compared to placebo over 48 weeks [64]